Advances in ADHD Treatment
hosted byConnect Educate Impact (CEI)
Advances in ADHD Treatment is organized by Connect Educate Impact (CEI).
Initial Release Date: June 1, 2022
Planned Expiration Date: June 1, 2025
Description:
Attention-deficit/hyperactivity disorder (ADHD) is the most common neurobehavioral disorder in children and can affect mental health throughout their lifetime. Take this course to learn about new medications in the pipeline that may offer better outcomes for our patients, and how to help patients choose the best pharmacologic and non-pharmacologic treatments.
Objectives:
Upon successful completion of this application-based CPE course, pharmacists should be able to:
• Review epidemiology, pathophysiology, symptoms, and diagnosis of ADHD in children and adolescents.
• Define non-pharmacologic and pharmacologic treatment of ADHD in children and adolescents.
• Discuss patient-specific factors and medication adverse effects to consider when choosing drug therapy for ADHD in children and adolescents.
• Describe new pharmacologic agents in the pipeline for ADHD.